Penalized nonlinear mixed effects model to identify biomarkers that predict disease progression

E-ISSN： 1541-0420|73|4|1343-1354

ISSN： 0006-341x

Source： BIOMETRICS, Vol.73, Iss.4, 2017-12, pp. : 1343-1354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Penalized regression for interval-censored times of disease progression: Selection of HLA markers in psoriatic arthritis

By Wu Ying Cook Richard J.

Biometrics, Vol. 71, Iss. 3, 2015-09 ,pp. : 782-791

Wiley-Blackwell

Access to resources Recommend Favorite

Penalized regression for interval‐censored times of disease progression: Selection of HLA markers in psoriatic arthritis

BIOMETRICS, Vol. 71, Iss. 3, 2015-09 ,pp. : 782-791

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating Tumor Stem Cells as Biomarkers for Cancer Progression

Recent Patents on Biomarkers, Vol. 2, Iss. 1, 2012-01 ,pp. : 36-53

Bentham Science Publishers

Access to resources Recommend Favorite

Model Selection and Mixed-Effects Modeling of HIV Infection Dynamics

By Bortz D. Nelson P.

Bulletin of Mathematical Biology, Vol. 68, Iss. 8, 2006-11 ,pp. : 2005-2025

Elsevier

Access to resources Recommend Favorite

A permutation approach for selecting the penalty parameter in penalized model selection

By Sabourin Jeremy A. Valdar William Nobel Andrew B.

Biometrics, Vol. 71, Iss. 4, 2015-12 ,pp. : 1185-1194

Wiley-Blackwell

Access to resources Recommend Favorite